First Time Loading...

Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 5.1 USD -1.35% Market Closed
Updated: May 4, 2024

Aurinia Pharmaceuticals Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aurinia Pharmaceuticals Inc
Cash from Financing Activities Peer Comparison

Comparables:
ZYME
TH
RPTX
FUSN
EDT

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cash from Financing Activities
-$5.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
Cash from Financing Activities
$81.8m
CAGR 3-Years
-36%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Cash from Financing Activities
$14.7m
CAGR 3-Years
-26%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Cash from Financing Activities
$842k
CAGR 3-Years
-85%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Cash from Financing Activities
$142m
CAGR 3-Years
-19%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Cash from Financing Activities
CA$5.4m
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
-1%

See Also

What is Aurinia Pharmaceuticals Inc's Cash from Financing Activities?
Cash from Financing Activities
-5.1m USD

Based on the financial report for Dec 31, 2023, Aurinia Pharmaceuticals Inc's Cash from Financing Activities amounts to -5.1m USD.